These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 23352967

  • 1. The complement system contributes to the pathology of experimental autoimmune encephalomyelitis by triggering demyelination and modifying the antigen-specific T and B cell response.
    Hundgeburth LC, Wunsch M, Rovituso D, Recks MS, Addicks K, Lehmann PV, Kuerten S.
    Clin Immunol; 2013 Mar; 146(3):155-64. PubMed ID: 23352967
    [Abstract] [Full Text] [Related]

  • 2. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J, Karacivi A, Stormanns ER, Recks MS, Kuerten S.
    PLoS One; 2015 Mar; 10(12):e0144847. PubMed ID: 26658811
    [Abstract] [Full Text] [Related]

  • 3. Myelin-reactive antibodies mediate the pathology of MBP-PLP fusion protein MP4-induced EAE.
    Kuerten S, Pauly R, Rottlaender A, Rodi M, Gruppe TL, Addicks K, Tary-Lehmann M, Lehmann PV.
    Clin Immunol; 2011 Jul; 140(1):54-62. PubMed ID: 21489887
    [Abstract] [Full Text] [Related]

  • 4. Four different synthetic peptides of proteolipid protein induce a distinct antibody response in MP4-induced experimental autoimmune encephalomyelitis.
    Recks MS, Grether NB, van der Broeck F, Ganscher A, Wagner N, Henke E, Ergün S, Schroeter M, Kuerten S.
    Clin Immunol; 2015 Jul; 159(1):93-106. PubMed ID: 25959684
    [Abstract] [Full Text] [Related]

  • 5. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
    Recks MS, Stormanns ER, Bader J, Arnhold S, Addicks K, Kuerten S.
    Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992
    [Abstract] [Full Text] [Related]

  • 6. Transient decomplementation of mice delays onset of experimental autoimmune encephalomyelitis and impairs MOG-specific T cell response and autoantibody production.
    Terényi N, Nagy N, Papp K, Prechl J, Oláh I, Erdei A.
    Mol Immunol; 2009 Nov; 47(1):57-63. PubMed ID: 19201476
    [Abstract] [Full Text] [Related]

  • 7. Delineating the impact of neuroantigen vs genetic diversity on MP4-induced EAE of C57BL/6 and B6.129 mice.
    Kuerten S, Rodi M, Javeri S, Gruppe TL, Tary-Lehmann M, Lehmann PV, Addicks K.
    APMIS; 2009 Dec; 117(12):923-35. PubMed ID: 20078558
    [Abstract] [Full Text] [Related]

  • 8. Involvement of brain-derived neurotrophic factor (BDNF) in MP4-induced autoimmune encephalomyelitis.
    Javeri S, Rodi M, Tary-Lehmann M, Lehmann PV, Addicks K, Kuerten S.
    Clin Immunol; 2010 Nov; 137(2):181-9. PubMed ID: 20797911
    [Abstract] [Full Text] [Related]

  • 9. Pathological and regulatory effects of anti-myelin antibodies in experimental allergic encephalomyelitis in mice.
    Morris-Downes MM, Smith PA, Rundle JL, Piddlesden SJ, Baker D, Pham-Dinh D, Heijmans N, Amor S.
    J Neuroimmunol; 2002 Apr; 125(1-2):114-24. PubMed ID: 11960647
    [Abstract] [Full Text] [Related]

  • 10. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.
    Elliott EA, McFarland HI, Nye SH, Cofiell R, Wilson TM, Wilkins JA, Squinto SP, Matis LA, Mueller JP.
    J Clin Invest; 1996 Oct 01; 98(7):1602-12. PubMed ID: 8833909
    [Abstract] [Full Text] [Related]

  • 11. Fundamental differences in the dynamics of CNS lesion development and composition in MP4- and MOG peptide 35-55-induced experimental autoimmune encephalomyelitis.
    Kuerten S, Javeri S, Tary-Lehmann M, Lehmann PV, Angelov DN.
    Clin Immunol; 2008 Nov 01; 129(2):256-67. PubMed ID: 18722816
    [Abstract] [Full Text] [Related]

  • 12. Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis.
    Breakell T, Tacke S, Schropp V, Zetterberg H, Blennow K, Urich E, Kuerten S.
    Int J Mol Sci; 2020 Sep 18; 21(18):. PubMed ID: 32962135
    [Abstract] [Full Text] [Related]

  • 13. Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis.
    Bail K, Notz Q, Rovituso DM, Schampel A, Wunsch M, Koeniger T, Schropp V, Bharti R, Scholz CJ, Foerstner KU, Kleinschnitz C, Kuerten S.
    J Neuroinflammation; 2017 Jul 24; 14(1):148. PubMed ID: 28738885
    [Abstract] [Full Text] [Related]

  • 14. Differential patterns of spinal cord pathology induced by MP4, MOG peptide 35-55, and PLP peptide 178-191 in C57BL/6 mice.
    Kuerten S, Gruppe TL, Laurentius LM, Kirch C, Tary-Lehmann M, Lehmann PV, Addicks K.
    APMIS; 2011 Jun 24; 119(6):336-46. PubMed ID: 21569091
    [Abstract] [Full Text] [Related]

  • 15. Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response.
    Kuerten S, Schickel A, Kerkloh C, Recks MS, Addicks K, Ruddle NH, Lehmann PV.
    Acta Neuropathol; 2012 Dec 24; 124(6):861-73. PubMed ID: 22842876
    [Abstract] [Full Text] [Related]

  • 16. The role of complement in the pathogenesis of experimental allergic encephalomyelitis.
    Linington C, Morgan BP, Scolding NJ, Wilkins P, Piddlesden S, Compston DA.
    Brain; 1989 Aug 24; 112 ( Pt 4)():895-911. PubMed ID: 2476195
    [Abstract] [Full Text] [Related]

  • 17. Central nervous system infiltrates are characterized by features of ongoing B cell-related immune activity in MP4-induced experimental autoimmune encephalomyelitis.
    Batoulis H, Wunsch M, Birkenheier J, Rottlaender A, Gorboulev V, Kuerten S.
    Clin Immunol; 2015 May 24; 158(1):47-58. PubMed ID: 25796192
    [Abstract] [Full Text] [Related]

  • 18. Anti-CD52 antibody treatment depletes B cell aggregates in the central nervous system in a mouse model of multiple sclerosis.
    Simon M, Ipek R, Homola GA, Rovituso DM, Schampel A, Kleinschnitz C, Kuerten S.
    J Neuroinflammation; 2018 Aug 11; 15(1):225. PubMed ID: 30098594
    [Abstract] [Full Text] [Related]

  • 19. Conventional housing conditions attenuate the development of experimental autoimmune encephalomyelitis.
    Arndt A, Hoffacker P, Zellmer K, Goecer O, Recks MS, Kuerten S.
    PLoS One; 2014 Aug 11; 9(6):e99794. PubMed ID: 24919069
    [Abstract] [Full Text] [Related]

  • 20. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
    Meeson AP, Piddlesden S, Morgan BP, Reynolds R.
    Exp Neurol; 1994 Oct 11; 129(2):299-310. PubMed ID: 7525334
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.